GO:0044665 MLL1/2 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044665 (MLL1/2 complex) is a histone H3 lysine-4 (H3K4) methyltransferase complex that contains either MLL1 (KMT2A) or MLL2 (KMT2B) as its catalytic subunit.
• The complex is part of the larger COMPASS family of H3K4 methylases, which are conserved from yeast to humans and regulate developmental gene expression.
• MLL1/2 complex activity is essential for stem cell maintenance and differentiation, including muscle satellite cells and planarian stem cells.
• Recruitment of the MLL1/2 complex to target genes such as HOX loci is mediated by sequence-specific transcription factors and cofactors like Carm1, Flightless-I, and Psip1/Ledgf.
• Dysregulation of MLL1/2 complex components is linked to leukemia, developmental disorders, and cancer, making it a target for epigenetic therapies.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of MLL1/2 complex subunits in disease and development.
Description
The MLL1/2 complex (GO:0044665) is a multi-subunit chromatin-modifying machine that catalyzes the methylation of histone H3 at lysine 4 (H3K4), a hallmark of active gene transcription. It is defined by the presence of either MLL1 (KMT2A) or MLL2 (KMT2B) as the catalytic subunit, which confers H3K4 methyltransferase activity. This complex belongs to the COMPASS family, a group of conserved H3K4 methylases that include SET1 in yeast and Trithorax (Trx) in Drosophila, reflecting its deep evolutionary roots. The MLL1/2 complex is often referred to as the Trx-containing complex due to its homology with the Drosophila Trithorax group proteins. Researchers study the MLL1/2 complex because it sits at the nexus of epigenetic regulation and cell fate decisions. It is required for the proper expression of HOX genes and other developmental regulators, and its dysfunction is associated with aggressive leukemias and solid tumors. In stem cells, the complex helps maintain an open chromatin state at lineage-specific genes, poising them for activation upon differentiation cues. Understanding how the MLL1/2 complex is assembled, recruited, and regulated is therefore critical for both basic developmental biology and translational cancer research. The complex is not a single static entity; rather, it exists in various configurations depending on the associated subunits and cellular context. For example, in muscle satellite cells, the MLL1/2 complex is recruited by Carm1 to regulate Pax7 transcriptional activity during asymmetric divisions. In planarians, the SET1/MLL family, including MLL1/2 homologs, controls stem cell self-renewal and differentiation. These diverse roles underscore the importance of precise experimental models to dissect its function.
MLL1/2 complex At A Glance
| GO ID | GO:0044665 |
|---|---|
| GO term | MLL1/2 complex |
| Ontology | cellular_component |
| Synonym | Trx-containing complex |
| Major function | Histone H3 lysine-4 methylation, transcriptional activation |
| Catalytic subunits | MLL1 (KMT2A) or MLL2 (KMT2B) |
| Conserved family | COMPASS family of H3K4 methylases |
| Cellular localization | Nucleus, chromatin-associated |
| Associated cofactors | Carm1, Flightless-I, Psip1/Ledgf, SENP3, BPTF |
What Is GO:0044665?
The MLL1/2 complex is a protein complex that can methylate lysine-4 of histone H3. It contains either of the protein subunits MLL1 or MLL2 in human, or equivalent proteins in other species. This definition from QuickGO (GO:0044665) highlights its catalytic activity and subunit composition, placing it within the cellular component ontology as a nuclear chromatin-modifying complex.
Why Is MLL1/2 complex Important in Cell Biology?
The MLL1/2 complex is a central regulator of gene expression programs that govern development and stem cell identity. Its ability to methylate H3K4 creates an epigenetic mark that promotes transcription, and its recruitment to specific loci is tightly controlled by signaling and transcription factors. Because mutations and translocations involving MLL1 (KMT2A) are recurrent in leukemia and other cancers, the complex is a high-priority target for understanding oncogenesis and for developing epigenetic therapies. Moreover, its roles in muscle stem cell commitment and planarian regeneration highlight its broad relevance to tissue homeostasis and regeneration.
• Regulates developmental gene expression, including HOX genes, through H3K4 methylation.
• Essential for stem cell maintenance and asymmetric division in muscle satellite cells.
• Controls stem cell self-renewal and differentiation in planarians, a model for regeneration.
• Implicated in leukemia and solid tumors via MLL1 (KMT2A) rearrangements and mutations.
• Recruited by transcription factors such as Carm1 and cofactors like Flightless-I and Psip1/Ledgf.
• Interacts with chromatin remodeling proteins like BPTF to maintain transcriptional stability.
• Subject to regulation by SUMOylation and isopeptidase SENP3 at HOX loci.
• Provides a paradigm for COMPASS family function across species, from Drosophila to humans.
• Offers therapeutic targets for epigenetic inhibitors in cancer and developmental disorders.
• Enables CRISPR-based functional genomics to dissect subunit-specific roles.
MLL1/2 complex: Biological Process, Structure, and Molecular Mechanism
What Happens During MLL1/2 complex?
In simple terms: The MLL1/2 complex acts as a molecular switch that marks histones to turn genes on.
The primary biological process mediated by the MLL1/2 complex is the methylation of histone H3 at lysine 4 (H3K4), which is associated with transcriptional activation. This process occurs in the nucleus, where the complex binds to chromatin at target gene promoters and enhancers. The catalytic subunits MLL1 or MLL2 transfer methyl groups from S-adenosylmethionine (SAM) to H3K4, leading to mono-, di-, or trimethylation. This mark serves as a docking site for effector proteins that promote RNA polymerase II recruitment and elongation. In stem cells, this activity maintains genes in a poised state, ready for activation upon differentiation signals. For example, in muscle satellite cells, Carm1 recruits the MLL1/2 complex to Pax7 target genes to regulate asymmetric divisions. In planarians, SET1/MLL family members, including MLL1/2 homologs, are required for stem cell self-renewal and differentiation.
Structure and Composition of MLL1/2 complex
In simple terms: The complex is like a machine with a core engine (MLL1 or MLL2) and many accessory parts that help it find and read genes.
The MLL1/2 complex is defined by the presence of either MLL1 (KMT2A) or MLL2 (KMT2B) as its catalytic core. These large proteins contain multiple domains, including the SET domain responsible for methyltransferase activity, as well as PHD fingers and bromodomains that recognize modified histones. The complex also includes common subunits shared with other COMPASS family members, such as WDR5, RBBP5, ASH2L, and DPY30, which are essential for catalytic activity and complex stability. Additional accessory proteins confer target specificity and regulation. For instance, Carm1 interacts with the MLL1/2 complex to regulate Pax7 transcriptional activity. Flightless-I recruits the SUMO isopeptidase SENP3 to distinct HOX genes, modulating MLL1/2 function. Psip1/Ledgf p75 recruits both trithorax and polycomb group proteins to restrain Hox gene expression. The chromatin remodeling protein BPTF also interacts with the complex to regulate transcriptional stability in stem cells. The composition can vary depending on cell type and developmental stage, allowing for context-dependent functions.
Molecular Mechanism of MLL1/2 complex
In simple terms: The complex uses a chemical reaction to add methyl marks to histones, which acts like a flag that tells the cell to read the gene.
The molecular function of the MLL1/2 complex is histone H3 lysine-4 methyltransferase activity. The catalytic SET domain of MLL1 or MLL2 binds to SAM and transfers methyl groups to the epsilon-amino group of H3K4. This reaction produces mono-, di-, or trimethylated H3K4, with trimethylation (H3K4me3) typically associated with active promoters. The activity is dependent on the integrity of the complex; associated subunits like WDR5, RBBP5, and ASH2L are required for optimal methyltransferase activity. Regulation occurs at multiple levels. Post-translational modifications, such as SUMOylation, can modulate complex recruitment; SENP3, a SUMO isopeptidase, is recruited by Flightless-I to HOX genes to regulate MLL1/2-mediated methylation. Additionally, the complex can be recruited by transcription factors like Carm1, which bridges it to specific targets. The interplay with Polycomb group proteins, as shown by Psip1/Ledgf, adds another layer of regulation, balancing activating and repressive marks.
Assembly and Recruitment of MLL1/2 complex
In simple terms: The complex is assembled from many parts and then guided to the right genes by helper proteins.
Assembly of the MLL1/2 complex involves the stepwise association of core subunits. The catalytic subunit MLL1 or MLL2 first binds to WDR5, which recognizes the N-terminal region of MLL proteins, followed by RBBP5, ASH2L, and DPY30 to form a functional methyltransferase module. This core complex is then recruited to chromatin by sequence-specific DNA-binding proteins and cofactors. For example, Carm1 directly interacts with MLL1/2 and is required for its recruitment to Pax7 target genes during muscle satellite cell asymmetric division. Flightless-I acts as an adaptor that recruits SENP3 to HOX loci, influencing MLL1/2 activity. Psip1/Ledgf p75 binds to H3K36me3 and recruits both trithorax (including MLL1/2) and polycomb group proteins to Hox genes, fine-tuning their expression. In planarians, the SET1/MLL family, including MLL1/2 homologs, is essential for stem cell function, though specific recruitment mechanisms are still being elucidated. The chromatin remodeling protein BPTF also contributes to transcriptional stability, potentially by facilitating MLL1/2 access to nucleosomes.
Key Genes Involved in GO:0044665 MLL1/2 complex
The following genes encode subunits or key interactors of the MLL1/2 complex, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KMT2A (MLL1) | Catalytic subunit, H3K4 methyltransferase | Leukemia, developmental disorders, stem cell biology |
| KMT2B (MLL2) | Catalytic subunit, H3K4 methyltransferase | Developmental disorders, cancer |
| WDR5 | Core subunit, binds MLL1/2 N-terminus | Complex assembly, therapeutic target |
| RBBP5 | Core subunit, required for methyltransferase activity | Complex integrity, cancer |
| ASH2L | Core subunit, stimulates catalytic activity | Complex assembly, epigenetics |
| DPY30 | Core subunit, stabilizes complex | Complex assembly |
| CARM1 | Coactivator, recruits MLL1/2 to Pax7 targets | Muscle stem cell asymmetric division |
| FLII (Flightless-I) | Adaptor, recruits SENP3 to HOX genes | HOX gene regulation, SUMOylation |
| SENP3 | SUMO isopeptidase, modulates MLL1/2 at HOX loci | HOX gene regulation |
| PSIP1 (Ledgf p75) | Recruits trithorax and polycomb to Hox genes | Hox gene restraint, chromatin regulation |
| BPTF | Chromatin remodeling protein, interacts with complex | Transcriptional stability in stem cells |
| PAX7 | Transcription factor, target of MLL1/2 via Carm1 | Muscle stem cell commitment |
| HOX genes | Target genes of MLL1/2 complex | Developmental regulation, leukemia |
| SET1 (yeast) | Homolog of MLL1/2 in COMPASS | Conserved H3K4 methylation |
| Trx (Drosophila) | Homolog of MLL1/2, Trithorax group | Developmental gene regulation |
| KMT2 family | H3K4 methyltransferases including MLL1/2 | Enzymatic and non-enzymatic functions |
How Is MLL1/2 complex Regulated?
The MLL1/2 complex is regulated at multiple levels. Its recruitment to target genes is controlled by transcription factors and cofactors such as Carm1, which bridges the complex to Pax7 during muscle stem cell division. Post-translational modifications, particularly SUMOylation, modulate its activity; the SUMO isopeptidase SENP3 is recruited by Flightless-I to HOX genes to regulate MLL1/2 function. Additionally, the complex interacts with Polycomb group proteins via Psip1/Ledgf p75, which restrains Hox gene expression, indicating a balance between activating and repressive chromatin states. Chromatin remodeling proteins like BPTF also contribute to the regulation of transcriptional stability in stem cells. These regulatory mechanisms ensure context-specific gene expression.
MLL1/2 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KMT2A (MLL1) | Acute leukemia, developmental disorders | Knockout/knock-in in hematopoietic stem cells |
| KMT2B (MLL2) | Developmental disorders, cancer | Point mutation knock-in in cell lines |
| CARM1 | Muscle stem cell dysfunction | Knockout in satellite cells |
| PSIP1 (Ledgf p75) | Hox gene dysregulation, cancer | Overexpression/knockdown in cancer cells |
| BPTF | Stem cell transcriptional instability | Knockout in planarian stem cells |
MLL1/2 complex in Leukemia and Cancer
Dysregulation of the MLL1/2 complex is strongly associated with hematological malignancies. MLL1 (KMT2A) is frequently rearranged in acute leukemias, leading to fusion proteins that alter H3K4 methylation patterns and drive leukemogenesis. Mutations in MLL2 (KMT2B) have also been implicated in various cancers. The complex's role in HOX gene regulation is particularly relevant, as aberrant HOX expression is a hallmark of MLL-rearranged leukemias. Targeting the catalytic activity or protein-protein interactions of the MLL1/2 complex is an active area of therapeutic development.
MLL1/2 complex in Developmental Disorders
Germline mutations in KMT2A and KMT2B cause developmental disorders characterized by intellectual disability, growth retardation, and facial dysmorphism. These conditions underscore the complex's critical role in neurodevelopment and gene regulation. The MLL1/2 complex is also essential for stem cell function in various tissues, and its disruption can lead to tissue-specific defects.
MLL1/2 complex in Muscle Stem Cell Biology
In muscle satellite cells, the MLL1/2 complex is recruited by Carm1 to regulate Pax7 transcriptional activity during asymmetric divisions. This process is essential for muscle regeneration and homeostasis. Dysregulation of this pathway may contribute to muscle wasting diseases and impaired regeneration. The dystrophin glycoprotein complex also regulates epigenetic activation of muscle stem cell commitment, potentially through interactions with MLL1/2.
From MLL1/2 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MLL1/2 complex subunit X have a catalytic-independent role? | Point mutation (e.g., SET domain inactive) knock-in |
| How does MLL1/2 complex recruitment affect HOX gene expression? | Knockout of recruitment factors (e.g., Carm1, Flightless-I) |
| What is the effect of MLL1/2 complex overexpression in cancer? | Overexpression cell models |
| Can we tag endogenous MLL1/2 complex for live imaging? | Tagged knock-in (e.g., GFP) |
| Which genes are directly regulated by MLL1/2 complex? | CRISPR knockout followed by RNA-seq/ChIP-seq |
| How does MLL1/2 complex interact with Polycomb proteins? | Knock-in of interaction domain mutations |
How to Study the MLL1/2 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genomic binding sites of MLL1/2 complex and H3K4me3 | Mapping target genes in leukemia cells |
| RNA-seq | Transcriptional changes upon complex perturbation | Identifying regulated pathways in stem cells |
| Co-IP/MS | Protein-protein interactions and subunit composition | Defining context-specific complexes |
| Western blot | Protein expression and histone methylation levels | Validating knockout/knockdown efficiency |
| Immunofluorescence | Subcellular localization and chromatin association | Visualizing complex recruitment |
| CRISPR screening | Genome-wide identification of essential subunits | Discovering novel regulators |
| Planarian regeneration assays | Stem cell self-renewal and differentiation | Functional studies in vivo |
| Muscle satellite cell culture | Asymmetric division and differentiation | Muscle stem cell biology |
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
ChIP-seq is used to map the genomic binding sites of MLL1/2 complex subunits and their associated histone marks, such as H3K4me3. By immunoprecipitating the complex or modified histones, researchers can identify target genes and regulatory elements. This method is essential for understanding how the complex is recruited to specific loci like HOX genes.
RNA Sequencing (RNA-seq)
RNA-seq measures global gene expression changes upon perturbation of MLL1/2 complex components. Knockout or knockdown of subunits followed by RNA-seq reveals the transcriptional programs controlled by the complex, including developmental regulators and HOX genes. This approach can also identify compensatory mechanisms and pathways.
Proteomics and Co-immunoprecipitation
Co-immunoprecipitation coupled with mass spectrometry identifies the subunit composition and interacting partners of the MLL1/2 complex. This is critical for defining context-specific complexes and understanding how accessory proteins like Carm1, Flightless-I, and Psip1/Ledgf modulate its function.
Functional Assays for Stem Cell Self-Renewal
In planarians and muscle satellite cells, functional assays such as clonogenic assays, regeneration studies, and differentiation markers are used to assess the role of MLL1/2 complex in stem cell maintenance. These assays link molecular function to tissue-level phenotypes.
How CRISPR Can Be Used to Study GO:0044665 MLL1/2 complex
Knockout
CRISPR knockout of MLL1/2 complex subunits (e.g., KMT2A, KMT2B, WDR5) is used to abolish complex function and assess its role in gene expression, cell proliferation, and differentiation. Knockout models in cell lines and primary cells have revealed essential roles in leukemia maintenance and stem cell self-renewal.
Point Mutation
Point mutations can be introduced into the catalytic SET domain of MLL1 or MLL2 to separate enzymatic activity from scaffolding functions. Such models help determine whether phenotypes are dependent on H3K4 methylation or on protein-protein interactions. For example, catalytically dead mutants can be compared to complete knockouts to reveal non-enzymatic functions.
Knock-in
Knock-in of tagged versions of MLL1/2 complex subunits (e.g., GFP or HA) allows for live-cell imaging, chromatin immunoprecipitation, and proteomic studies. Knock-in of disease-associated mutations (e.g., in KMT2A) can model leukemia and developmental disorders.
Overexpression
Overexpression of wild-type or mutant MLL1/2 complex subunits is used to study gain-of-function effects, such as oncogenic transformation or altered differentiation. Overexpression models can also help identify dominant-negative effects and test therapeutic inhibitors.
How EDITGENE Supports MLL1/2 complex Research
Researchers studying MLL1/2 complex-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to generate such models, enabling rigorous functional studies of the MLL1/2 complex.
Contact EDITGENE today to design your custom CRISPR model for MLL1/2 complex research.
Frequently Asked Questions About MLL1/2 complex
What is the MLL1/2 complex?
The MLL1/2 complex (GO:0044665) is a protein complex that methylates histone H3 at lysine 4 and contains either MLL1 (KMT2A) or MLL2 (KMT2B) as its catalytic subunit.
What genes are involved in the MLL1/2 complex?
Key genes include KMT2A (MLL1), KMT2B (MLL2), WDR5, RBBP5, ASH2L, DPY30, and accessory factors like CARM1, FLII, SENP3, and PSIP1.
What is the function of the MLL1/2 complex?
It catalyzes H3K4 methylation to activate gene expression, particularly of developmental regulators such as HOX genes, and is essential for stem cell maintenance.
How is the MLL1/2 complex recruited to target genes?
Recruitment is mediated by transcription factors and cofactors such as Carm1, Flightless-I, and Psip1/Ledgf, which bind to specific chromatin regions and interact with the complex.
What diseases are associated with MLL1/2 complex mutations?
Mutations and rearrangements in KMT2A and KMT2B are linked to acute leukemias, developmental disorders, and various cancers.
How can CRISPR be used to study the MLL1/2 complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect subunit-specific functions, catalytic activity, and disease mechanisms.
What is the COMPASS family?
COMPASS is a conserved family of H3K4 methyltransferase complexes that includes the MLL1/2 complex in humans and SET1 in yeast.
What is the role of MLL1/2 complex in muscle stem cells?
It is recruited by Carm1 to regulate Pax7 transcriptional activity during asymmetric satellite stem cell divisions, influencing muscle regeneration.
How does the MLL1/2 complex interact with Polycomb proteins?
Psip1/Ledgf p75 recruits both trithorax (including MLL1/2) and polycomb group proteins to Hox genes, balancing activating and repressive marks.
What methods are used to study the MLL1/2 complex?
Common methods include ChIP-seq, RNA-seq, co-immunoprecipitation, proteomics, and functional assays in stem cells and model organisms.
Conclusion
The MLL1/2 complex (GO:0044665) is a critical epigenetic regulator that controls gene expression through H3K4 methylation. Its roles in stem cell biology, development, and disease make it a focal point for both basic and translational research. Understanding its assembly, recruitment, and regulation requires precise experimental models, and CRISPR-based approaches offer powerful tools to dissect its functions. EDITGENE provides comprehensive services to support such studies, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Van HT et al.. 2024. KMT2 Family of H3K4 Methyltransferases: Enzymatic Activity-dependent and -independent Functions.. J Mol Biol 436(7):168453 PMID: 38266981
- 2. Kawabe Y et al.. 2012. Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions.. Cell Stem Cell 11(3):333-45 PMID: 22863532
- 3. Verma P et al.. 2024. Chromatin remodeling protein BPTF regulates transcriptional stability in planarian stem cells.. bioRxiv PMID: 38826365
- 4. Nayak A et al.. 2017. Flightless-I governs cell fate by recruiting the SUMO isopeptidase SENP3 to distinct HOX genes.. Epigenetics Chromatin 10:15 PMID: 28344658
- 5. Chang NC et al.. 2018. The Dystrophin Glycoprotein Complex Regulates the Epigenetic Activation of Muscle Stem Cell Commitment.. Cell Stem Cell 22(5):755-768.e6 PMID: 29681515
- 6. Mohan M et al.. 2011. The COMPASS family of H3K4 methylases in Drosophila.. Mol Cell Biol 31(21):4310-8 PMID: 21875999
- 7. Hubert A et al.. 2013. Epigenetic regulation of planarian stem cells by the SET1/MLL family of histone methyltransferases.. Epigenetics 8(1):79-91 PMID: 23235145
- 8. Pradeepa MM et al.. 2014. Psip1/Ledgf p75 restrains Hox gene expression by recruiting both trithorax and polycomb group proteins.. Nucleic Acids Res 42(14):9021-32 PMID: 25056311
